It was first started by Eli Lilly nearly 70 years ago and split off into its own publicly traded company in 2019. An artist’s rendering of the new Elanco corporate headquarters near downtown ...

Eli Lilly, the Indianapolis-based drugmaker behind pharmaceuticals such as Mounjaro, acquired the 84,000-square-foot facility at 10300 128th Ave. from Nexus in April 2024 with plans to use the ...

Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...

INDIANAPOLIS — Eli Lilly announced Wednesday the launch of higher doses of Zepbound — and that the company is lowering the price of certain doses. People taking Zepbound, or interested in starting, ...

SHANGHAI (Reuters) -Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval from Chinese regulators,... INDIANAPOLIS - Eli Lilly and Company (NYSE:LLY) announced successful ...

INDIANAPOLIS — Eli Lilly and Company is announcing a massive new set of investments in U.S. manufacturing. The company plans to more than double its investments since 2020, bringing the total to more ...

Eli Lilly and Co. Wednesday announced ... 13,000 manufacturing and construction jobs. Lilly will invest $27 billion in the four plants, the Indianapolis drugmaker announced at a press conference ...

Eli Lilly said Wednesday it will invest $27 billion ... the threat of drug import duties from the Trump administration. The Indianapolis-based company said three of the planned facilities will ...

INDIANAPOLIS - Eli Lilly and Company (NYSE:LLY), the global pharmaceutical giant, has announced a second-quarter dividend of $1.30... Eli Lilly & Co. (NYSE:LLY) declared a quarterly dividend ...

Eli Lilly, based in Indianapolis, says it is in negotiations with several states about the expansions. Economic development officials in North Carolina declined to say whether the state is in ...

The Indianapolis-based company has announced that it is selling higher doses of Zepbound in single-dose vials at as much as half its usual list price, depending on the dosage. Eli Lilly says it is ...

Eli Lilly has unveiled a $27bn investment in US ... offensive aimed at President Donald Trump’s new administration. The Indianapolis-based drugmaker announced plans to plough money into four ...